Status:
TERMINATED
Red Blood Cell Lifespan
Lead Sponsor:
Renal Research Institute
Conditions:
Chronic Kidney Disease
Hemodialysis
Eligibility:
All Genders
18-88 years
Brief Summary
Background: A low amount of red blood cells in the blood of patients with limited kidney function is a well known problem. Besides the lack of substances in the blood like iron or erythropoietin the ...
Eligibility Criteria
Inclusion
- Age greater than 18 years
- Chronic hemo- or peritoneal dialysis treatment greater than 3 months
Exclusion
- Inability to understand the English language and give informed consent for participation in the study
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT01462071
Start Date
May 1 2008
End Date
March 1 2013
Last Update
February 24 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yorkville Dialysis Center
New York, New York, United States, 10128